LRMR icon

Larimar Therapeutics
LRMR

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13
175% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
Laura Chico
75% 1-yr LRMR win rate
3 Mar ‘26 1 month ago
Citigroup
Citigroup
Samantha Semenkow
100% 1-yr LRMR win rate
25 Feb ‘26 1 month ago